Endometriosis
Showing NaN - NaN of 15
Endometriosis Trial in Worldwide (Relugolix, Estradiol/norethindrone acetate)
Active, not recruiting
- Endometriosis
- Relugolix
- Estradiol/norethindrone acetate
-
Andalusia, Alabama
- +168 more
May 31, 2022
Endometriosis Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate, Placebo for Elagolix, Elagolix)
Active, not recruiting
- Endometriosis
- Estradiol/Norethindrone Acetate
- +3 more
-
Birmingham, Alabama
- +196 more
Feb 14, 2022
Women Receiving Standard of Care for Treatment of Pelvic Pain
Terminated
- Endometriosis
- +2 more
-
Birmingham, Alabama
- +116 more
Nov 16, 2021
Validation Study for Endometriosis PRO
Completed
- Endometriosis
- No drug
-
Jonesboro, Arkansas
- +20 more
Oct 10, 2014
Endometriosis Trial in Canada, Russian Federation, United States (Danazol Once Weekly, Danazol Twice Weekly, Placebo Once
Completed
- Endometriosis
- Danazol Once Weekly
- +3 more
-
Chandler, Arizona
- +48 more
Mar 2, 2012
Endometriosis Trial in United States (NBI-56418 (GnRH antagonist), )
Completed
- Endometriosis
- NBI-56418 (GnRH antagonist)
- placebo
-
Phoenix, Arizona
- +14 more
Feb 21, 2012